Tauklarify is a newly approved imaging drug that makes Alzheimer's tau tangles visible on brain PET scans. For adults with new memory symptoms, the news means doctors have another evaluation tool, not a diagnosis by itself. Tauklarify is florquinitau F 18 injection, an F-18-labeled tracer.
Tau tangles are clumps of abnormal tau protein that can disrupt brain cells. Reuters reported the FDA approval on Aug. 14, 2026, in the FDA approval report.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
What the scan shows
The tracer is injected before a PET scan. It sticks to clumped tau, so abnormal deposits appear in brain images. This helps doctors characterize disease stage during an Alzheimer's workup.
Enigma Biomedical announced the indication for adults with cognitive impairment being evaluated for Alzheimer's disease in the company approval announcement. The scan identifies tau tangle pathology, one key marker of Alzheimer's. It does not replace memory testing, lab work, or other brain scans. It adds biological detail when the cause of thinking problems remains unclear.
Who it is meant for
The intended group is adults who already have cognitive impairment and need Alzheimer's evaluation. Examples include repeated trouble recalling recent events, getting lost in familiar places, or struggling to follow plans. The Society of Nuclear Medicine and Molecular Imaging notes Tauklarify is the second approved tau PET tracer after flortaucipir, in the Society's tracer update.
It can complement amyloid PET, which detects a different Alzheimer's protein. People without symptoms do not fit the labeled use. Safety and effectiveness are not established for other tau diseases, and performance may be lower at earlier stages.
What results cannot prove
A clear result does not guarantee a specific diagnosis. A positive scan does not always confirm tau disease, and a negative scan does not always rule it out. That limit matters because memory loss has many causes.
Vascular injury, sleep apnea, depression, thyroid problems, vitamin deficiency, and medication effects can mimic dementia. Doctors order more tests when uncertainty remains. Think of Tauklarify as one puzzle piece. History, exam findings, cognitive scores, labs, and other imaging still shape the final judgment.
What to do about new memory symptoms
See a doctor promptly for new trouble with memory or clear thinking. The National Institute on Aging advises evaluation with history, cognitive tests, labs, and brain imaging to find the cause and guide referral.
Bring concrete notes to the visit: The tracer adds to lifetime radiation exposure and needs safe handling. Patients should follow instructions on fluids and, when relevant, short-term breastfeeding interruption.
- examples of recent memory lapses and dates
- current drugs, vitamins, alcohol use, and sleep habits
- family history of dementia and stroke
- questions about specialist referral and scan options
